1 |
ABBOTT LABORATORIES et al v. LUPIN LIMITED et al |
2:09-cv-01007 |
D.N.J. |
|
|
|
|
2 |
ABBOTT LABORATORIES et al v. LUPIN LIMITED et al |
2:09-cv-01007 |
D.N.J. |
|
|
|
|
3 |
Alcon Pharmaceuticals Ltd et al v. Lupin Ltd. et al |
1:12-cv-00973 |
D.Del. |
|
|
|
|
4 |
Alcon Pharmaceuticals Ltd et al v. Lupin Ltd. et al |
1:12-cv-00973 |
D.Del. |
|
|
|
|
5 |
Alcon Research, Ltd. v. Watson Laboratories, Inc., et al., |
1:15-cv-01159 |
D.Del. |
|
|
|
|
6 |
Allergan, Inc. v. Lupin Ltd. et al |
6:11-cv-00611 |
E.D.Tex. |
|
|
|
|
7 |
Anacor Pharmaceuticals, Inc. v. Lupin Limited et al |
1:18-cv-01606 |
D.Del. |
|
|
|
|
8 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
9 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
10 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
11 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
12 |
ASTRAZENECA AB et al v. LUPIN LTD. et al |
3:15-cv-06092 |
D.N.J. |
|
|
|
|
13 |
Aventis Pharma Deutschland GMBH et al v. Lupin Ltd. et al |
2:05-cv-00421 |
E.D.Va. |
|
|
|
|
14 |
Aventis Pharma Deutschland GMBH et al v. Lupin Ltd. et al |
2:05-cv-00421 |
E.D.Va. |
|
|
|
|
15 |
Aventis Pharma Deutschland GmbH et al v. Lupin Ltd. et al |
1:05-cv-01936 |
D.Md. |
|
|
|
|
16 |
Aventis Pharma Deutschland GmbH et al v. Lupin Ltd. et al |
1:05-cv-01936 |
D.Md. |
|
|
|
|
17 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
18 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
19 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
20 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
21 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
22 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
23 |
Bristol-Myers Squibb & Gilead Sciences, LLC v. Lupin Ltd. |
2:14-cv-00795 |
E.D.Tex. |
|
|
|
|
24 |
Cephalon Inc. et al v. Lupin Limited et al |
1:10-cv-00210 |
D.Del. |
|
|
|
|
25 |
Cephalon Inc. et al v. Lupin Limited et al |
1:10-cv-00210 |
D.Del. |
|
|
|
|
26 |
Cephalon, Inc. et al v. Lupin Limited et al |
1:10-cv-00661 |
D.Md. |
|
|
|
|
27 |
Cephalon, Inc. et al v. Lupin Limited et al |
1:10-cv-00661 |
D.Md. |
|
|
|
|
28 |
Eisai Co. Ltd. et al. v. Lupin Ltd., et al. |
1:13-cv-01281 |
D.Del. |
|
|
|
|
29 |
Eisai Co. Ltd. et al. v. Lupin Ltd., et al. |
1:13-cv-01281 |
D.Del. |
|
|
|
|
30 |
Eisai Co. Ltd. et al. v. Lupin Ltd., et al. |
1:13-cv-01281 |
D.Del. |
|
|
|
|
31 |
ELI LILLY AND COMPANY et al v. LUPIN PHARMACEUTICALS, INC et al |
1:15-cv-01047 |
S.D.Ind. |
|
|
|
|
32 |
ELI LILLY AND COMPANY et al v. LUPIN PHARMACEUTICALS, INC et al |
1:15-cv-01047 |
S.D.Ind. |
|
|
|
|
33 |
ELI LILLY AND COMPANY et al v. LUPIN PHARMACEUTICALS, INC et al |
1:15-cv-01047 |
S.D.Ind. |
|
|
|
|
34 |
Eli Lilly and Company et al v. Lupin Pharmaceuticals, Inc. et al |
1:15-cv-00877 |
E.D.Va. |
|
|
|
|
35 |
Eli Lilly and Company et al v. Lupin Pharmaceuticals, Inc. et al |
1:15-cv-00877 |
E.D.Va. |
|
|
|
|
36 |
Eli Lilly and Company et al v. Lupin Pharmaceuticals, Inc. et al |
1:15-cv-00877 |
E.D.Va. |
|
|
|
|
37 |
ELI LILLY AND COMPANY v. LUPIN LIMITED et al |
1:08-cv-01596 |
S.D.Ind. |
|
|
|
|
38 |
Gilead Sciences, Inc. v. Lupin Ltd. |
2:14-cv-00796 |
E.D.Tex. |
|
|
|
|
39 |
Gilead Sciences, Inc., et al v. Lupin Limited |
1:12-cv-06293 |
S.D.N.Y. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
40 |
Gilead Sciences, Inc., et al v. Lupin Limited |
1:12-cv-06293 |
S.D.N.Y. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
41 |
GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al |
2:23-cv-00018 |
D.N.J. |
|
|
|
|
42 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
43 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
44 |
HORIZON PHARMA IRELAND LIMITED et al v. LUPIN LTD. et al |
1:15-cv-06935 |
D.N.J. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
45 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
46 |
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL. |
2:17-cv-11635 |
D.N.J. |
|
|
|
|
47 |
HORIZON THERAPEUTICS, LLC v. LUPIN LTD. et al |
1:16-cv-04438 |
D.N.J. |
|
|
|
|
48 |
HORIZON THERAPEUTICS, LLC v. LUPIN LTD. et al |
2:17-cv-05900 |
D.N.J. |
|
|
|
|
49 |
HORIZON THERAPEUTICS, LLC v. LUPIN LTD. et al |
1:16-cv-04438 |
D.N.J. |
|
|
|
|
50 |
iCeutica Pty Ltd. et al v. Lupin Limited et al |
1:14-cv-01515 |
D.Del. |
|
|
|
|